硬化性GVHD和硬化性共享失调的基因表达,由EREG治疗性抗体改善
Nathan M Newton1,2,3, Kriti Agrawal2,4, Anahi V Odell1
1Department of Dermatology, Yale School of Medicine, New Haven, CT.
Blood
|September 17, 2025
概括
一种针对epiregulin (EREG) 的新抗体有效地减少了皮肤纤维化在免疫驱动疾病,如皮质硬化症. 这种疗法针对关键的炎症和纤维化通路,为改善患者结果提供希望.
科学领域:
- 免疫皮肤学 免疫皮肤学
- 纤维化研究纤维化.
- 治疗性抗体的开发方法
背景情况:
- 免疫驱动的纤维性皮肤疾病,如硬化症/全身性硬化症 (SSc) 和慢性移植对宿主疾病 (GVHD),导致衰弱的皮肤硬.
- 目前用于纤维化皮肤表现的治疗方法在很大程度上是无效的,这凸显了未得到满足的临床需求.
- 皮肤上生长因子受体 (EGFR) 连接体Epiregulin (EREG) 在纤维化皮肤中升高,对纤维化维持至关重要.
研究的目的:
- 开发和评估一种全人类抗EREG中和抗体,用于治疗纤维化皮肤疾病.
- 阐明EREG向SSc,形态和硬化性GVHD (SclGVHD) 的抗纤维化机制.
主要方法:
- 开发一种高亲和度,完全特定的人类抗EREG抗体.
- 在人体EREG knockin小鼠中对抗体的安全性和功能进行了体内验证.
- 在患者皮肤样本中分析单细胞和空间转录组,以确定分子机制.
- 测量与纤维化和炎症相关的蛋白质生物标志物.
主要成果:
- 反EREG抗体在临床前模型中证明了安全性和有效性.
- 在SSc,morphea和SclGVHD中,EREG表达升高,从而驱动肌纤维细胞的tenascin C (TNC) 生产.
- 用抗体向EREG减少了炎症生物标志物 (CCL2,IL-6) 和纤维细胞标志物 (TNC,原I,FN1).
- 空间转录组学显示,在接受治疗的SclGVHD皮肤扩展体中,矩阵降解 (MMP) 的增加和抑制剂 (TIMP1) 的降低.
结论:
- 用中和抗体向EREG是一种有前途的治疗策略,用于免疫驱动的纤维化皮肤疾病.
- 抗体有效地减少关键的炎症和纤维化信号通路,包括由EGFR和Toll-like受体4 (TLR4) 介导的.
- 这种方法有可能改善严重纤维化皮肤病患者的皮肤生活质量和治疗结果.
相关概念视频
01:22iPS Cell Differentiation
3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K
01:19Clinical Applications of Epidermal Stem Cells
3.3K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.3K
01:11Genome-wide Association Studies-GWAS
15.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.3K